glp-1 7-36 amide (7-36), (TFA) GLP-1 (9-36) AMIDE (HUMAN, BOVINE,
Description
It is typically most effective when paired with balanced nutrition, regular activity, hydration, and long-term lifestyle support
Elkind-Hirsch KE, Chappell N, Shaler D, Storment J, Bellanger D
Novo Nordisk, the maker of these weight-loss drugs, does not include warnings about the increased risk of gastroparesis/stomach paralysis (frozen stomach) for people who consume the medications or receive GLP-1 RA treatments
doi: 10.1016/j.bbr.2018.08.006
GLP-1 enhances insulin secretion and inhibits glucagon-release in a glucose-dependent manner both in normal individuals as well as in patients with type 2 diabetes [51]
